ARCHIVES

Highlights of NCDDGs: 3 Drugs on Market, 12 in Development; Advisors Approve Plan to Issue $10.5 Million Contract For Pediatric Preclinical Testing Program

This article is from The Cancer Letter archive.

Vol. 28 No. 44 | November 29, 2002

Download PDF Visit The Full Archive

Related Articles

In Brief: ACCC to Bid On Ovarian Cancer Treatment RFP; Community MDs Handle 90% Of Ovarian Patients

September 5, 1975

In Brief: Resolution Seeks Two-Fold Increase For NIH; Hartwell Named President At Fred Hutchinson

January 31, 1997

TGen’s Trent To Lead Van Andel Institute

February 13, 2009

Taxol Patents Reveal Bristol Strategy to Safeguard Market Against Competitors

July 4, 1997

States Join Suit Alleging Amgen Offered Illegal Kickback To Doctors For Aranesp

November 6, 2009

Von Eschenbach says he will continue as NCI director and give both jobs “100 percent.”

September 30, 2005